UK markets closed

Clearside Biomedical, Inc. (CLSD)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.3100-0.0100 (-0.76%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
8,226
8,226
1,327
29,575
7,894
Cost of revenue
355
355
204
0
0
Gross profit
7,871
7,871
1,123
29,575
7,894
Operating expenses
Research development
20,846
20,846
19,630
18,537
15,073
Selling general and administrative
11,869
11,869
11,770
11,665
10,756
Total operating expenses
32,715
32,715
31,400
30,202
25,829
Operating income or loss
-24,844
-24,844
-30,277
-627
-17,935
Interest expense
9,360
9,360
3,339
0
0
Total other income/expenses net
1,719
1,719
669
1,003
-275
Income before tax
-32,485
-32,485
-32,947
376
-18,210
Income from continuing operations
-32,485
-32,485
-32,947
376
-18,210
Net income
-32,485
-32,485
-32,947
376
-18,210
Net income available to common shareholders
-32,485
-32,485
-32,947
376
-18,210
Basic EPS
-0.61
-
-0.55
0.01
-0.39
Diluted EPS
-0.61
-
-0.55
0.01
-0.39
Basic average shares
61,308
-
60,205
58,492
46,507
Diluted average shares
61,308
-
60,205
59,907
46,507